Get started
IN8bio, Inc.IN8bio, Inc.IN8bio, Inc.

IN8bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

INAB chart


Full chart

INAB upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪16.08 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.8285 USD
Net income (FY)
‪−30.01 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪32.04 M‬
Beta (1Y)
3.25

Employees


Employees (FY)
31
Change (1Y)
+5 +19.23%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−967.97 K‬ USD

About IN8bio, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
William T. Ho
Website
in8bio.com
Headquarters
New York
Founded
2016
FIGI
BBG00XX9K1M2
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

INAB news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of INAB is 0.3436 USD — it has increased by 3.93% in the past 24 hours. Watch IN8bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange IN8bio, Inc. stocks are traded under the ticker INAB.
INAB stock has risen by 22.63% compared to the previous week, the month change is a 44.07% rise, over the last year IN8bio, Inc. has showed a −68.48% decrease.
We've gathered analysts' opinions on IN8bio, Inc. future price: according to them, INAB price has a max estimate of 6.50 USD and a min estimate of 1.50 USD. Watch INAB chart and read a more detailed IN8bio, Inc. stock forecast: see what analysts think of IN8bio, Inc. and suggest that you do with its stocks.
INAB reached its all-time high on Aug 11, 2021 with the price of 10.3190 USD, and its all-time low was 0.2170 USD and was reached on Oct 8, 2024. View more price dynamics on INAB chart.
See other stocks reaching their highest and lowest prices.
INAB stock is 8.97% volatile and has beta coefficient of 3.25. Track IN8bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is IN8bio, Inc. there?
Today IN8bio, Inc. has the market capitalization of ‪16.08 M‬, it has decreased by −15.62% over the last week.
Yes, you can track IN8bio, Inc. financials in yearly and quarterly reports right on TradingView.
IN8bio, Inc. is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
INAB earnings for the last quarter are −0.19 USD per share, whereas the estimation was −0.17 USD resulting in a −9.62% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about IN8bio, Inc. earnings.
IN8bio, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
INAB net income for the last quarter is ‪−8.63 M‬ USD, while the quarter before that showed ‪−8.56 M‬ USD of net income which accounts for −0.78% change. Track more IN8bio, Inc. financial stats to get the full picture.
No, INAB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 31.00 employees. See our rating of the largest employees — is IN8bio, Inc. on this list?
Like other stocks, INAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IN8bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IN8bio, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IN8bio, Inc. stock shows the sell signal. See more of IN8bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.